Biotech Startups
9,992 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.
0 investors
CureLab Veterinary develops ElenaVet, a plasmid DNA gene therapy encoding the p62/SQSTM1 protein to reduce chronic inflammation and enhance anticancer immune response in pets, targeting conditions such as breast cancer, melanoma, osteoarthritis and inflammatory bowel disease in dogs, cats and horses. The company works with academic and private veterinary clinics through comparative medicine studies and is a sister company of CureLab Oncology, which focuses on human immuno-oncology.
0 investors
Curemark is a clinical-stage biopharmaceutical company developing therapies for neuro-developmental and neurodegenerative disorders. Its lead candidate, CM-AT, is a disorder-modifying therapy for Autism.
0 investors
0 investors
0 investors
0 investors
CvergenX develops the precisionRT Dose (pRTD) platform, which uses gene-expression biomarkers (RSI) and the Genomic Adjusted Radiation Dose (GARD) metric to predict tumor radiosensitivity and personalize radiotherapy dosing. It provides predictive analytics for biologically guided radiation oncology, serving clinical and research use in cancer treatment.
0 investors
Cx Precision Medicine develops blood-based diagnostic tests for Alzheimer's and other neurodegenerative diseases, delivering precision medicine tools for early diagnosis and personalized treatment in primary care settings.
0 investors
0 investors
0 investors
0 investors
0 investors
CYduct Diagnostics (CYductDX) develops and markets medical devices for breast cancer risk assessment, early detection, and diagnosis through an intraductal approach within the mammary ducts. It serves women and their clinicians, applying genetic and proteomic testing to breast health in the medical device and diagnostics industry.
0 investors
0 investors
0 investors
0 investors
Cypris Medical develops minimally-invasive medical devices and treatments designed specifically for plastic surgeons to deliver results comparable to traditional surgery with shorter recovery times. The company combines medical device expertise with input from practicing surgeons to address unmet needs in the plastic surgery market.
0 investors
Cyprium Therapeutics develops therapies for rare genetic diseases, with a focus on treatments for Menkes disease. The company's pipeline includes ZYCUBO (copper histidinate) and AAV-ATP7A gene therapy candidates.
0 investors
Cyrcadia Health develops technology based on circadian rhythm science to detect tissue disruption and cancer risk. The company's core innovation relates circadian clock dysregulation to cancer development and prognosis.
0 investors
0 investors